{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:27Z","timestamp":1790888727998,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejps.2025.107019","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T03:11:20Z","timestamp":1736997080000},"page":"107019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The impact of community pharmacies on equity in access to professional rapid antigen testing for SARS-CoV-2 in Portugal"],"prefix":"10.1016","volume":"206","author":[{"given":"Jos\u00e9","family":"Guerreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-0996","authenticated-orcid":false,"given":"S\u00f3nia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Dimitrovov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00faben","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio Teixeira","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107019_bib0001","doi-asserted-by":"crossref","DOI":"10.21138\/bage.3160","article-title":"Spatial inequalities of COVID-19 incidence and associated socioeconomic risk factors in Portugal","author":"Almendra","year":"2021","journal-title":"Boletin de la Asociacion de Geografos Espanoles"},{"key":"10.1016\/j.ejps.2025.107019_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.scs.2022.104158","article-title":"What have we learned about socioeconomic inequalities in the spread of COVID-19? A systematic review","volume":"86","author":"Benita","year":"2022","journal-title":"Sustain. Cities. Soc."},{"key":"10.1016\/j.ejps.2025.107019_bib0003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J. Am. Pharmacists Assoc."},{"key":"10.1016\/j.ejps.2025.107019_bib0004","first-page":"19","article-title":"Covid-19: control measures must be equitable and inclusive","volume":"368","author":"Berger","year":"2020","journal-title":"The BMJ"},{"key":"10.1016\/j.ejps.2025.107019_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diagnostics11091685","article-title":"Knowledge, attitudes, and behavior related to covid-19 testing: a rapid scoping review","volume":"11","author":"Bevan","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejps.2025.107019_bib0006","unstructured":"Canadian Pharmacists Association, 2021. Payment for Pharmacy Services [WWW Document]. URL https:\/\/www.pharmacists.ca\/advocacy\/scope-of-practice\/payment-for-pharmacy-services\/(accessed 4.29.24)."},{"key":"10.1016\/j.ejps.2025.107019_bib0007","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.3390\/ijerph17217945","article-title":"Flu vaccinations in pharmacies-a review of pharmacists fighting pandemics and infectious diseases","volume":"17","author":"Czech","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ejps.2025.107019_bib0008","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/antibiotics9110743","article-title":"Point-of-care testing for pharyngitis in the pharmacy","volume":"9","author":"Essack","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejps.2025.107019_bib0009","unstructured":"GEOSTAT initiative - GISCO - Eurostat [WWW Document], n.d. URL https:\/\/ec.europa.eu\/eurostat\/web\/gisco\/gisco-activities\/integrating-statistics-geospatial-information\/geostat-initiative (accessed 2.18.22)."},{"key":"10.1016\/j.ejps.2025.107019_bib0010","doi-asserted-by":"crossref","first-page":"A623","DOI":"10.1016\/j.jval.2016.09.1593","article-title":"The impact of community pharmacies (CP) on regional equity in the access to the Portuguese needle and exchange programme (NEP)","volume":"19","author":"Gouveia","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.ejps.2025.107019_bib0011","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PHH.0000000000000482","article-title":"Potential for pharmacy-public health collaborations using pharmacy-based point-of-care testing services for infectious diseases","volume":"23","author":"Gubbins","year":"2017","journal-title":"J. Public Health Manag. Practice"},{"key":"10.1016\/j.ejps.2025.107019_bib0012","unstructured":"HSE Ireland, 2023. Circular number NCO-37-2023: COVID-19 and seasonal influenza vaccination programme autumn winter 2023\/2024 [WWW Document]. URL https:\/\/www.hse.ie\/eng\/staff\/pcrs\/circulars\/pharmacy\/nco-37-2023-community-pharmacy-circular-covid-19-seasonal-influenza-vaccination-2023-24.pdf (accessed 4.29.24)."},{"key":"10.1016\/j.ejps.2025.107019_bib0013","unstructured":"INFARMED - National Authority of Medicines and Health Products, I.P., 2022. Testes COVID-19. Farm\u00e1cias e outras entidades registadas para realiza\u00e7\u00e3o de testes r\u00e1pidos de antig\u00e9nio de uso profissional [COVID-19 Tests: pharmacies and other registered entities authorized to perform professional-use rapid antigen tests \u201ctext in Portuguese\u201d] [WWW Document]. URL https:\/\/www.infarmed.pt\/web\/infarmed\/testes-covid-19 (accessed 2.9.22)."},{"key":"10.1016\/j.ejps.2025.107019_bib0014","doi-asserted-by":"crossref","DOI":"10.5888\/pcd13.160232","article-title":"Provision of clinical preventive services by community pharmacists","volume":"13","author":"Kelling","year":"2016","journal-title":"Prev. Chronic. Dis."},{"key":"10.1016\/j.ejps.2025.107019_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/14737159.2021.1944105","article-title":"The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing","volume":"21","author":"Klepser","year":"2021","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ejps.2025.107019_bib0016","first-page":"30","article-title":"Organized colorectal cancer screening, towards the end of a French paradox with the delivery of the kit in pharmacies","volume":"62","author":"Le Duc-Banaszuk","year":"2023","journal-title":"Actualit\u00e9s Pharmaceut."},{"key":"10.1016\/j.ejps.2025.107019_bib0017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<729::AID-SIM491>3.0.CO;2-A","article-title":"Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index","volume":"16","author":"Lee","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejps.2025.107019_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13756-021-01039-x","article-title":"What matters: non-pharmaceutical interventions for COVID-19 in Europe","volume":"11","author":"Liu","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.ejps.2025.107019_bib0019","doi-asserted-by":"crossref","DOI":"10.1596\/1813-9450-10034","article-title":"The impact of COVID-19 on global inequality and poverty","volume":"10198","author":"Mahler","year":"2022","journal-title":"Policy Res. Working Papers"},{"key":"10.1016\/j.ejps.2025.107019_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050043","article-title":"Rapid realist review of the role of community pharmacy in the public health response to COVID-19","volume":"11","author":"Maidment","year":"2021","journal-title":"BMJ Open."},{"key":"10.1016\/j.ejps.2025.107019_bib0021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jac\/dkac358","article-title":"Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11\u200a304 consultations using anonymized electronic pharmacy records","volume":"78","author":"Mantzourani","year":"2022","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ejps.2025.107019_bib0022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.annepidem.2021.07.007","article-title":"Increasing concentration of COVID-19 by socioeconomic determinants and geography in Toronto, Canada: an observational study","volume":"65","author":"Mishra","year":"2022","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ejps.2025.107019_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298713","article-title":"Factors influencing the uptake of public health interventions delivery by community pharmacists: a systematic review of global evidence","volume":"19","author":"Mumbi","year":"2024","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2025.107019_bib0024","unstructured":"NHS England, 2023. Community pharmacy advanced service specification Seasonal influenza vaccination 1 September 2023 - 31 March 2024 [WWW Document]. URL https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2023\/08\/PRN00628-cp-seasonal-influenza-vaccination-as-specification-23-24-august-2023.pdf (accessed 4.21.24)."},{"key":"10.1016\/j.ejps.2025.107019_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.japh.2020.09.021","article-title":"Pharmacist-initiated treatment of minor conditions: a call to action","volume":"61","author":"Page","year":"2021","journal-title":"J. Am. Pharmacists Assoc."},{"key":"10.1016\/j.ejps.2025.107019_bib0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1715163520903065","article-title":"Community pharmacy\u2013based H. pylori screening for patients with uninvestigated dyspepsia","volume":"153","author":"Papastergiou","year":"2020","journal-title":"Can. Pharm. J. (Ott)"},{"key":"10.1016\/j.ejps.2025.107019_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1226922","article-title":"Impacts of public health and social measures on COVID-19 in Europe: a review and modified Delphi technique","volume":"11","author":"Paulo","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ejps.2025.107019_bib0028","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.mayocp.2020.11.024","article-title":"COVID-19: understanding inter-individual variability and implications for precision medicine","volume":"96","author":"Pereira","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejps.2025.107019_bib0029","unstructured":"Portugal. DGS\/INFARMED\/INSA, 2021. Circular informativa conjunta n.o 001\/CD\/100.20.200 de 12\/02\/2021. COVID-19, Operacionaliza\u00e7\u00e3o da utiliza\u00e7\u00e3o dos Testes R\u00e1pidos de Antig\u00e9nio (TRAg) \u20132a atualiza\u00e7\u00e3o [Circular Number 001\/CD\/100.20.200 of 02\/12\/2021. COVID-19, Operationalization of the use of Rapid Antigen Tests (TRAg) \u20132nd update \u201cText in Portuguese\u201d]."},{"key":"10.1016\/j.ejps.2025.107019_bib0030","unstructured":"Portugal. Minist\u00e9rio da Sa\u00fade, 2021a. Portaria n.o 138-B\/2021. Estabelece um regime excecional e tempor\u00e1rio de comparticipa\u00e7\u00e3o de testes r\u00e1pidos de antig\u00e9nio (TRAg) de uso profissional [Ordinance No. 138-B\/2021. Establishes an exceptional and temporary reimbursement scheme for professional use rapid antigen tests (TRAg) \u201ctext in Portuguese\u201d]. Di\u00e1rio da Rep\u00fablica n.o 125\/2021 2 Suplemento, 67(2)-67(4)."},{"key":"10.1016\/j.ejps.2025.107019_bib0031","unstructured":"Portugal. Minist\u00e9rio da Sa\u00fade, 2021b. Portaria n.o 255-A\/2021. Estabelece um regime excecional e tempor\u00e1rio de comparticipa\u00e7\u00e3o de testes r\u00e1pidos de antig\u00e9nio (TRAg) de uso profissional [Ordinance No. 255-A\/2021. Establishes an exceptional and temporary scheme for the reimbursement of professional-use rapid antigen tests (Ag-RDT) \u201ctext in Portuguese\u201d]. Di\u00e1rio da Rep\u00fablica n.o 224\/2021 1 Suplemento, 2\u20134."},{"key":"10.1016\/j.ejps.2025.107019_bib0032","unstructured":"Portugal. Minist\u00e9rio da Sa\u00fade. Dire\u00e7\u00e3o Geral da Sa\u00fade., 2022. Norma no 019\/2020 de 26\/10\/2020 atualizada a 23\/06\/2022. COVID-19: estrat\u00e9gia Nacional de Testes para SARS-CoV-2 [Standard No. 019\/2020 of 10\/26\/2020, updated on 06\/23\/2022. COVID-19: National Testing Strategy for SARS-CoV-2 \u201ctext in Portuguese\u201d] 1\u201313."},{"key":"10.1016\/j.ejps.2025.107019_bib0033","unstructured":"Portugal. Minist\u00e9rio das Finan\u00e7as e Sa\u00fade, 2023. Portaria n.o 289\/2023. Define os termos e as condi\u00e7\u00f5es da presta\u00e7\u00e3o de vacina\u00e7\u00e3o por parte das farm\u00e1cias na Campanha de Vacina\u00e7\u00e3o Sazonal do Outono-Inverno 2023-2024, bem como a respetiva remunera\u00e7\u00e3o [Ordinance No. 289\/2023. Defines the terms and conditions for the provision of vaccination services by pharmacies during the 2023-2024 Autumn-Winter Seasonal Vaccination Campaign, as well as the corresponding remuneration \u201ctext in Portuguese\u201d]. Di\u00e1rio da Rep\u00fablica n.o 187\/2023 S\u00e9rie I, 56\u201357."},{"key":"10.1016\/j.ejps.2025.107019_bib0034","unstructured":"R\u00e9publique Fran\u00e7aise, 2024. Viruses -Seasonal influenza vaccination: campaign extended until 29 February | Service-Public.fr [WWW Document]. URL https:\/\/www.service-public.fr\/particuliers\/actualites\/A15259?lang=en (accessed 4.29.24)."},{"key":"10.1016\/j.ejps.2025.107019_bib0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10729-020-09538-w","article-title":"Selecting pharmacies for COVID-19 testing to ensure access","volume":"24","author":"Risanger","year":"2021","journal-title":"Health Care Manage Sci."},{"key":"10.1016\/j.ejps.2025.107019_bib0036","series-title":"Li\u00e7\u00f5es Da Pandemia: Aprender Com Uma Experi\u00eancia Limite, Povos e Culturas","first-page":"1","author":"Romano","year":"2023"},{"key":"10.1016\/j.ejps.2025.107019_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ypmed.2018.08.029","article-title":"Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review","volume":"115","author":"San-Juan-Rodriguez","year":"2018","journal-title":"Prev. Med. (Baltim)"},{"key":"10.1016\/j.ejps.2025.107019_bib0038","unstructured":"Statistics Portugal, 2022a. Resident population by place of residence (2021) [WWW Document]. URL https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&contecto=pi&indOcorrCod=0000256&selTab=tab0&xlang=en (accessed 2.10.22)."},{"key":"10.1016\/j.ejps.2025.107019_bib0039","unstructured":"Statistics Portugal, 2022b. Ageing ratio (No.) by place of residence (2020) [WWW Document]. URL https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0008614&contexto=bd&selTab=tab2 (accessed 2.10.22)."},{"key":"10.1016\/j.ejps.2025.107019_bib0040","unstructured":"Statistics Portugal, 2022c. Per capita purchasing power by geographic localization (2020) [WWW Document]. URL https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0008614&contexto=bd&selTab=tab2 (accessed 2.10.22)."},{"key":"10.1016\/j.ejps.2025.107019_bib0041","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s11096-023-01679-6","article-title":"The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review","volume":"46","author":"Swart","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.ejps.2025.107019_bib0042","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckae144.384","article-title":"The impact of Portuguese community pharmacies on influenza vaccination accessibility and coverage","volume":"34","author":"Teixeira Rodrigues","year":"2024","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.ejps.2025.107019_bib0043","series-title":"Health Inequity and the Effects of COVID-19: assessing, Responding to and Mitigating the Socioeconomic Impact On Health to Build a Better future. Licence: CC BY-NC-SA 3.0 IGO","year":"2020"},{"key":"10.1016\/j.ejps.2025.107019_bib0044","series-title":"Overview of Public Health and Social Measures in the Context of COVID-19 [WWW Document]","year":"2020"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:14:55Z","timestamp":1755011695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"alternative-id":["S0928098725000181"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107019","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of community pharmacies on equity in access to professional rapid antigen testing for SARS-CoV-2 in Portugal","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107019"}}